| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Casamento Charles J is a Director at ETON, with reported holdings spanning 4 companies. Recent filings cover 9 purchases and 28 sales. Those positions are worth an estimated $3.1M at current prices.
Our model assigns Casamento Charles J a strong insider score of 71/100, based on 9 past trades. Over a 12-month horizon, 77.8% of those trades were profitable, with an average 12-month return of +39.8%.
Casamento Charles J's largest disclosed position is in ETON as Director, worth about $3.0M. Net of sales, the recent Form 4 record there shows accumulation of 8,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 | ETON Eton Pharmaceuticals, Inc. | Director | Buy | 5,000 | $6.00 | $30,000.00 | +7.9% | |
| Dec 14, 2015 | RLMD Relmada Therapeutics, Inc. | Director | Buy | 4,200 | $2.97 | $12,464.00 | +35.6% |